Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes: A Long-Term Cost-Effectiveness Analysis in Estonia
Crossref DOI link: https://doi.org/10.1007/s13300-018-0542-x
Published Online: 2018-12-07
Published Print: 2019-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Malkin, Samuel J. P.
Russel-Szymczyk, Monika
Liidemann, Girtel
Volke, Vallo
Hunt, Barnaby http://orcid.org/0000-0001-5420-279X
Article History
Received: 12 October 2018
First Online: 7 December 2018